Cargando…

Correction to: Long-term effectiveness and safety of self-management of oral anticoagulants in real-world settings

Detalles Bibliográficos
Autores principales:	Menéndez-Jándula, Bárbara, García-Erce, José Antonio, Zazo, Clara, Larrad-Mur, Luis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6880353/ https://www.ncbi.nlm.nih.gov/pubmed/31771510 http://dx.doi.org/10.1186/s12872-019-1268-z

Ejemplares similares

Long-term effectiveness and safety of self-management of oral anticoagulants in real-world settings
por: Menéndez-Jándula, Bárbara, et al.
Publicado: (2019)

Correction: Cost-effectiveness of apixaban compared to other anticoagulants in patients with atrial fibrillation in the real-world and trial settings
por: de Jong, Lisa A., et al.
Publicado: (2022)

Real-world monitoring of direct oral anticoagulants in clinic and hospitalization settings
por: Takatsuki, Seiji, et al.
Publicado: (2017)

Correction to: Drug–Drug Interactions with Direct Oral Anticoagulants
por: Foerster, Kathrin I., et al.
Publicado: (2020)

Correction to: Long-term Effectiveness and Safety of Upadacitinib for Atopic Dermatitis in a Real-world Setting: An Interim Analysis Through 48 Weeks of Observation
por: Chiricozzi, Andrea, et al.
Publicado: (2023)

Correction to: Reversal agents for oral anticoagulant-associated major or life-threatening bleeding
por: Moia, Marco, et al.
Publicado: (2019)

Correction: Uptake of direct oral anticoagulants in primary care: an ecological and economic study
Publicado: (2020)

Correction: Real-world effectiveness of osteoporosis treatments in Germany
por: O’Kelly, James, et al.
Publicado: (2022)

Publisher Correction to: Chlormethine Gel for Patients with Mycosis Fungoides Cutaneous T Cell Lymphoma: A Review of Efficacy and Safety in Clinical Trial and Real-World Settings
por: Wehkamp, Ulrike, et al.
Publicado: (2023)

Correction to: Real-World Safety of Intravitreal Bevacizumab and Ranibizumab Treatments for Retinal Diseases in Thailand: A Prospective Observational Study
por: Sangroongruangsri, Sermsiri, et al.
Publicado: (2019)

Correction to: Real-World Treatment Patterns in Patients with Vitiligo in the United States
por: Rosmarin, David, et al.
Publicado: (2023)

Correction to: REal worlD Effectiveness and Safety of Mepolizumab in a Multicentric Spanish Cohort of Asthma Patients Stratified by Eosinophils: The REDES Study
por: Domingo Ribas , Christian, et al.
Publicado: (2021)

Risks and benefits of direct oral anticoagulants versus warfarin in a real world setting: cohort study in primary care
por: Vinogradova, Yana, et al.
Publicado: (2018)

Correction: The Role of Anticoagulation in Treating Portal Hypertension
por: Turco, Laura, et al.
Publicado: (2018)

Correction: Carotid Artery Stenting: A Single Center “Real World” Experience
por: Krasniqi, Nazmi, et al.
Publicado: (2012)

Correction to: Effectiveness and safety of nivolumab in patients with head and neck cancer in Japanese real‑world clinical practice: a multicentre retrospective clinical study
por: Hanai, Nobuhiro, et al.
Publicado: (2021)

Correction to: Learning the effects of psychotropic drugs during pregnancy using real‑world safety data: a paradigm shift toward modern pharmacovigilance
por: Lupattelli, Angela, et al.
Publicado: (2020)

Effectiveness and Safety of Direct Oral Anticoagulants in Thai Patients with Atrial Fibrillation: A Real-World Retrospective Cohort Study
por: Srikajornlarp, Saowaluk, et al.
Publicado: (2022)

Efficacy and Safety of Antithrombotic Therapy With Oral Anticoagulants in Real-World Elderly Patients With Acute Coronary Syndrome and Atrial Fibrillation
por: Wu, Yangxun, et al.
Publicado: (2022)

Effectiveness and safety of oral anticoagulant therapy in a real-world cohort with atrial fibrillation: The SIESTA-A study protocol
por: Montero-Balosa, M. C., et al.
Publicado: (2023)

Effectiveness and safety of self-managed oral anticoagulant therapy compared with direct oral anticoagulants in patients with atrial fibrillation
por: Grove, Erik Lerkevang, et al.
Publicado: (2018)

Oral Anticoagulants Initiation in Patients with Atrial Fibrillation: Real-World Data from a Population-Based Cohort
por: Rodríguez-Bernal, Clara L., et al.
Publicado: (2017)

Correction: Real-world use of natalizumab in Austria: data from the Austrian Multiple Sclerosis Treatment Registry (AMSTR)
por: Monschein, Tobias, et al.
Publicado: (2023)

Correction: Physicians’ real-world experience with IDegLira: results of a European survey
Publicado: (2018)

Correction for: Real-world effectiveness of medications on survival in patients with COPD-heart failure overlap
por: Su, Vincent Yi-Fong, et al.
Publicado: (2019)

Correction to: Real-world bone turnover marker use: impact on treatment decisions and fracture
por: Lane, N. E., et al.
Publicado: (2021)

Correction: Real‑world data: a brief review of the methods, applications, challenges and opportunities
por: Liu, Fang, et al.
Publicado: (2023)

Publisher Correction: Sensitivity and specificity of blood-fluid levels for oral anticoagulant-associated intracerebral haemorrhage
por: Almarzouki, Abeer, et al.
Publicado: (2021)

Correction: Appropriateness of initial dose of non-vitamin K antagonist oral anticoagulants in patients with non-valvular atrial fibrillation in the UK
Publicado: (2019)

Correction to: Nationwide randomised trial evaluating elective neck dissection for early stage oral cancer (SEND study) with meta-analysis and concurrent real-world cohort
por: Hutchison, Iain L., et al.
Publicado: (2021)

Correction: Effectiveness of an impedance cardiography guided treatment strategy to improve blood pressure control in a real-world setting: results from a pragmatic clinical trial
Publicado: (2021)

Correction: Effectiveness of an impedance cardiography guided treatment strategy to improve blood pressure control in a real-world setting: results from a pragmatic clinical trial
Publicado: (2021)

Comparative effectiveness and safety of oral anticoagulants for atrial fibrillation in real-world practice: a population-based cohort study protocol
por: Holbrook, Anne, et al.
Publicado: (2016)

What can we learn from real world studies on direct oral anticoagulants?
por: Coppens, M.
Publicado: (2017)

Real-world study of direct oral anticoagulant dosing patterns in patients with atrial fibrillation
por: Gustafson, Whitney L., et al.
Publicado: (2019)

Use of Oral Anticoagulation in a Real‐World Population With Device Detected Atrial Fibrillation
por: Kaplan, Rachel M., et al.
Publicado: (2020)

Direct Oral Anticoagulants: From Randomized Clinical Trials to Real-World Clinical Practice
por: Roberti, Roberta, et al.
Publicado: (2021)

To learn or not to learn from real-world experience on direct oral anticoagulants in pediatric patients?
por: Streif, Werner
Publicado: (2023)

Primary Nonadherence to Oral Anticoagulants in Patients with Atrial Fibrillation: Real-World Data from a Population-Based Cohort
por: Rodriguez-Bernal, Clara L., et al.
Publicado: (2018)

Correction to: Real-World Recurrence Rates and Economic Burden in Patients with Resected Early-Stage Melanoma
por: Jang, Sekwon, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_cj2oefp2q2f04g6p3e7u2b9er8